TNFRSF17 and systemic lupus erythematosus: Therefore, we aimed to evaluate BCMA expression on B cell subsets in an independent cohort of 14 SLE patients under stable treatment with intravenous belimumab (SLE-BEL) in comparison to SLE patients receiving conventional therapy (SLE-SOC).